middle east hospital magazine january 2011

MEDICA 2010 Special Feature

MIDDLE EAST HOSPITAL Health & Innovations Awards 2010 Nominations

SAUDI MEDICARE 2011 Al Mishari Hospital – Saudi Healthcare Excellence

WORLD HEALTH CONGRESS ABU DHABI

HEALTHCARE MANAGEMENT FORUM 2011 – HEALTHCARE INSURANCE FORUM 2011

outstanding contributionto healthcare in the

Middle East

MEH

201

0

Health and Innovation Awa

rd

www.middleeasthospital.com

WEILL CORNELL MEDICAL COLLEGE IN QATAR – Spearheading Educational Excellence in the region

The definitive

guide to

Hospitals and

Healthcare

in the

Middle East

MIDDLE EAST HOSPITAL

Mirage Health Group

Adam,Rouilly

Medibord


Middle East

MEH

201

0


rd

MIDDLE EAST HOSPITAL Health & Innovations Awards nominations, Saudi Medicare 2011

Dr Abdulrahman Al Mishari Hospital – Saudi Healthcare excellence

Healthcare in the UAE at the Crossroads by Nusrate Ibrahim

Arab Health 2011, World Health Care Congress Middle East Review

Interview with Snoring Disorders Centre founder Dr Michael Oko

Malem Medical – World leader in Enuresis Alarms

MIDDLE EAST

MIDDLE EAST

MIDDLE EAST HOSPIT

ALThe definitiv

guide to

Hospitals and

HealthcarSPITTA

eThe definitiv

guide to

Hospitals and

eHealthcar

in the

Middle East

in the

Middle East

www

p.middleeasthospwww

ppital.com

The 14th International Healthcare, Hospital Supplies and Medical Equipment Show

10 - 13 APRIL 2011Riyadh International Convention & Exhibition Center

Be wherethe world

is going& growing

Middle East Hospital

January 2011 contents4. COVER FEATURE

Weill Cornell Medical College in Qatar:working on multiple fronts to improve healthcare in Qatar

12. Arab Health 2011 Preview

14. Adam,Rouilly: over 90 years of medical training expertise

16. Healthcare in the UAE at the crossroads: expert article by Nusrate Ibrahim of Deloitte

22. Malem Medical: world leaders in enuresis alarms

24. Saudi Medicare 2011: conference preview- 10-13April 2011 in Riyadh

26. Dr Abdulrahman Al Mishari Hospital: special feature on the lead-ing Saudi hospital

33. UK Pavilion at Arab Health

28. MEH Health 2010 and Innovation awards nominees: rewarding compa nies and providersmaking oustanding contributions to healthcare in theMiddle East

34. Mirage Health Group:New ear care products- ProScoop and ProTectlaunched at Arab Health

36. Philips Healthcare: Obstructive Sleep Apnea inthe Middle East and the benefits of CPAP treatment

42. Interview with Dr MichaelOko: consultant ENT surgeon and founder of theSnoring Disorders Centre

44. World Health Care Con-gress Middle East:Post-congress report

48. Special report:Diabetes in the Gulf and MENA region

Editor’s intro

Editor: Guy Rowland Publisher: Mike Tanousis Associate Publisher: Chris Silk

MEH Publishing LimitedCompany Number 7059215151 Church RdShoeburynessEssex SS3 9EZUnited KingdomTel: 0044 1702 296776

January 2011 | 3

Mobile: 0044 0776 1202468Skype -mike.tanousis1MEH French officeGuy RowlandTel : 0033 [email protected]

MEH agent for EgyptDr.Amr SalahMillennium International Group(Managing Director)

[email protected]: +2 0222736354Fax: +2 022747691Mobile: +2 0122227209

UAE distributorDr Prem Jagyasi MD & CEOExHealth 501 Ibn Sina BuildingP. O. Box. 505131Dubai HealthCare City, UAE

Tel:+971 4 437 0170 [email protected] www.ExHealth.com

To discuss the submission of anarticle for Middle East Hospitalmagazine please email [email protected]

January is an important month forthe healthcare industry in theMiddle East, with Arab Health inDubai a key date in the calendar.MEH will be at the event with astand in Dubai Room A. Thisfollows hot on the heels of Medica,and the inaugural World HealthCare Congress Middle East, a newand prestigious health care eventconvening global thought leadersand key decision makers from allsectors of healthcare to shareglobal best practices on health careinnovation and improvement. Thistook place in Abu Dhabi inDecember, with MEH official mediapartners.

Looking at the year ahead, the nextkey industry gathering in the regionwill be at Saudi Medicare 2011,from 10-13 April. The Saudi marketis the largest and therefore mostimportant in the Gulf, and thegrowth of this show, now in its 14thyear, reflects the opportunities forexporters of medical equipment tothe Kingdom. MEH is the leadmedia partner, and we preview theevent in this issue. For thoseinterested in finding out more aboutthe Saudi market, and making localcontacts, there will be a receptionduring Arab Health at the Fairmontin Dubai on 26 January from 6.30-8.30pm.The MEH 2010 Health andInnovation awards nominations are

well underway, with some of thenominees featured in this issue.Lord Darzi, UK businessambassador, will present some ofthe UK nominees with theircertificates at Arab Health in theNovotel at 5pm on 24 January.

Our cover feature this month is aprofile of the internationallyrenowned Weill Cornell Medical

College in Qatar, in which welook at the contribution thecollege is making toheathcare in the region. Alsofeatured is an interview withDr Michael Oko, founder ofthe UK based Snore Centre,who will be at Arab Health toraise awareness of theproblems caued by sleepapnea in the Middle East.

As it completes its first decade,Weill Cornell Medical Collegein Qatar has graduated 49 newphysicians, established aresearch program focused onthe genetic and molecularbasis of diseases challengingthe Gulf Region and the world,and expanded access tosuperior clinical care for thecountry’s fast-growingpopulation.

“As we advance our triple missionof excellence in education,research and clinical care, we areimplementing the vision of HerHighness Sheika Mozah BintNasser Al Missned for aknowledge-based society and asustainable economy in Qatar,”says Javaid sheikh, M.D., dean ofWCMC-Q.

From its start, with 25 students inthe premedical program, themedical college has grown rapidlyto more than 262 students from 35countries. Following the curriculum

of Weill Cornell Medial College inthe United States, the medicalcollege introduced to Qatar co-education at the university level andthe problem-based learning methodwith its emphasis on independent,self-directed study to increaseknowledge and understanding andfacilitate communication skills andteamwork.

The graduation of its fourth class inMay brings to more than 75 thenumber of physicians who havereceived the M.D. degree fromCornell University. These newdoctors are now enrolled inresidency or fellowship trainingprograms with renowned hospitalsin the United States and at HamadMedical Corporation in Qatar, thecountry’s leading non-profit healthcare provider.

As they continue their training,many of these young doctors aremaking their mark on theinstitutions they join. Subhi Al Aref,M.D., a graduate of WCMC-Q’sinaugural class of 2008, wasrecently appointed to a four-year

term on the board of directors of theWCMC Alumni Association, the firstappointment from the Qatarcampus. A senior resident ininternal medicine at NewYork-Presbyterian Hospital, Dr. Al Arefrecently received an interventionalcardiology fellowship as well. ImranFarooq, M.D., a 2009 graduate,was recently named chief residentof internal medicine at the MedicalCollege of Virginia at VirginiaCommonwealth University.Additionally, his gastroenterologyresearch will be presented in Mayat a large gastroenterologyconference in the U.S.

As the graduates increase innumber, they advance thereputation of WCMC-Q in the widerange of organizations they join.

An Oasis for Research andNew Knowledge Through its biomedical researchprogram, WCMC-Q scientists andresearchers are investigating thegenetic and molecular causes ofdiseases challenging the GulfRegion and the world.

Weill Cornell Medical College in QatarWorking on Multiple Fronts to Improve Health Care in Qatar


January 2011 | 4

With strong financial support fromQatar Foundation, WCMC-Q hasestablished a strong researchinfrastructure with core laboratoriesshared by the entire researchdepartment, supporting multipleexperiments and studies for basicand clinical research.

Core facilities established to dateinclude: • a genomics core thatprovides DNA and RNA analysisservices• an imaging core to improveunderstanding of cellularphysiology; and • a biostatics core, withexpertise in study design and dataanalysis related to clinical studies.

While establishing the genomicscore laboratory two years ago,WCMC-Q researchers tackledsequencing the date palm genomeas a proof of concept project tovalidate the capabilities of the lab.Within two months, the team wasable to generate a draft DNAsequence of the genome. “Weincreased a thousand fold thepublicly available knowledge of the

date palm gene space,” says JoelMalek, director of the genomicslaboratory. “As importantly, theproject demonstrated the lab’scapabilities to the application ofadvanced genomics technology fora better understanding ofbiomedical problems,” he says.

Additional shared core facilitiessoon will be available, including avivarium for keeping and raising

research animals; a proteomics core labto identify proteins and assist incharacterization of protein modificationand differential expression; abioinformatics core to help with theapplication of statistics and computerscience to the management of biologicaldata; and a clinical research supportcore to provide protocol development,study design, monitoring and reprtingof clinical studies.

Premedical students work on an experiment in the chemistry lab


January 2011 | 5

“This robust infrastructure,supported by our strongadministrative structure, facilitatesthe progress of all our researchersand improves their productivity andefficiency,” says Khaled Machaca,Ph.D., associate dean for research.“Shared expertise, information, andresources help us develop criticalmass in research and avoidduplication of efforts; and itfacilitates the transfer of knowledgeand technologies to Qatar.”

WCMC-Q investigators haveundertaken dozens of researchstudies into areas with internationalsignificance, such ascardiovascular diseases, cancergenetics, stem cell therapies,vaccine development for infectiousdiseases, as well as areas withlocal significance, such asstrategies for slowingdesertification, and the healtheffects of shisha smoking.

The work has strong financialsupport from the Qatar NationalResearch Fund, which hasawarded grants through theNational Priorities ResearchProgram (NPRP) to WCMC-Q

investigators totaling more than $33million. With its focus on promotingresearch that directly benefitsQatar, the NPRP requires 50percent of its supported research tobe conducted inside Qatar.

The requirement not only ensuresthat the research program buildshuman capital in Qatar, but alsohelps turn Qatar into aninternational hub for advanced

scientific research by encouragingcollaboration with research centersaround the world.

“Already research conducted byour investigators solely in Qataris appearing in majorinternational publications,providing solid evidence thatour work is generating importantnew knowledge,” saysMachaca.

Investigators in the biomedical research program focus on genetic andmolecular causes of disease


January 2011 | 6

SERVING MEDICALEDUCATION WORLDWIDE

ANATOMICAL MODELS, SIMULATORS AND CHARTS FOR CLINICAL SKILLS AND TRAINING

www.adam-rouilly.co.uk

STAND: 7G59

Bringing the DalmSymposium to QatarWCMC-Q is bringing a majorinternational conference ondiabetes and related disordersto Qatar in March with thesupport of Qatar Foundationand the Lorenzini Foundation inMilan, Italy. The XVIIInternational DALM Symposium,which will be held in DohaMarch 14-16, will focus on thecauses and treatments fordiabetes, obesity and themetabolic syndrome, whichhave become huge public healthchallenges for Qatar and theGulf Region.

“The symposium is an importantstep in making scientificfindings on the emergingpandemic more accessible tophysicians and health carepractitioners in the Middle East,”says Dr. Sheikh, M.D. “As Qatar’sonly medical college, we welcomethe opportunity to help bringscientists and physicians togetherto focus on a significant issue inpatient care,” says Dr. Sheikh.

Long-term attention to the healthchallenges posed by diabetes andrelated disorders in Qatar and theGulf Region will be provided by aresearch center focused on thecauses and treatments of thedisorder. The Center for Diabetes,Obesity and Metabolic Syndromewill be home to a collaborative,multidisciplinary research teamfocused on diabetes and relatedendocrine, nutritional and metabolicdiseases that are a leading causeof death not only in Qatar but alsoin the rest of the world.

WCMC-Q students are encouragedto embrace the research culturethroughout the medical program.Through biannual grants from theUndergraduate ResearchExperience Program (UREP),students conduct research underthe guidance of experienced facultymembers. The students have usedthe grants to study topics rangingfrom cancer diagnostics at thegenetic level and the public

perception of the genetic disorderDown Syndrome in Qatar topurification of drinking water andcare for patients with diabetes. WCMC-Q supplements externalfunding with its own programs toencourage students to use theirsummers to participate in researchin established labs in Qatar and theU.S. and present their findings totheir peers upon their return.

Expanding Access to Clinical CareNearly a dozen WCMC-Q clinicalfaculty members provide the latestin medical care to hundreds ofpatients at weekly outpatient clinicsheld at partner hospitals in Qatar.

While most WCMC-Q physicianspractice at Hamad MedicalCorporation, others arecredentialed to provide care atAspetar Orthopedic SportsMedicine Hospital.

“As we educate our students, wecontinually educate ourselves andthat translates into better care forpatients,” says Dr. Bakr Nour,associate dean for clinical affairsand professor of surgery who seesmore than a dozen patients at hisregular weekly clinic. His colleague,surgical oncologist Arash RafiiTabrizi, M.D., has expanded thekinds of laparoscopic surgeries

The class of 2010 in the Clinical Skills Center


January 2011 | 8

The world’soneandonly

● 12 independent specific-time vibrating alarms● 12 recordable messages for each of the specific-time selections● Periodic auto-repeat vibrating alarm with recordable message● Ability to select vibrating alarm with or without message● No loss of programme information while changing battery

For use with:● Dementia, Alzheimer’s, Autism, the Elderly,

People with Special Needs, Memory Loss & Diurnal Enuresis

Reminder for:● Taking Medication, Bladder Emptying,

Timed Voiding, General Daily Routines(eating, drinking etc.), Appointments,and Behavioural ModificationProgrammes

DescriptionThe Malem© Vibro-Watch© + Record is a digitalmultifunctional watch with 12 independent specific-timevibration alarms and a specific auto-repeat vibratingalarm (range from 1 minute to 23:59 hours). Each of theselectable vibrating alarms can be accompanied with aspecific recorded 10 second message. The Vibro-Watch©

displays real time in hours (12/24, am/pm), minutes,seconds, month date, day of the week and also has astop watch.Any of the set vibrating alarms can be accompanied withthe recorded message. Selected specific-time or periodic auto-repeat vibration/messagealarms can be easily activated or de-activated (on or off). All programmed information isheld in permanent memory so no information is lost while changing the battery.

Malem Medical10 Willow Holt, Lowdham, Nottingham

NG14 7EJ, England, UKTel: + 44 (0)115 966 4440 Fax: + 44 (0)115 966 4672

E-mail: [email protected]: www.malem.co.uk Web: www.malemmedical.co.uk

© Malem Medical 2010

Vibro-Watch©+ RecordMultifunctionalVibrating AlarmWatch with recordable messages

prolongs independent living at home

ModelMO16

done in Qatar, giving patients thebenefit of smaller incisions andshorter recovery times. Dr RafiiTabrizi is also working with HMC totrain more physicians in theminimally invasive surgicaltechnique.

Through a recent affiliationagreement with Sidra Medical andResearch Center, WCMC-Q will bethe primary clinical partner forQatar’s newest academic healthcenter. The 450-bed hospital,which is scheduled to open in 2012,will allow WCMC-Q students tolearn the best patient care, usingSidra’s advanced technologiessuch as robotics, computer-aidedsurgery and diagnostics, digitalimaging and electronic patientrecords. WCMC-Q faculty will beinvolved in Sidra’s patient care,research, medical education andresident training.

“Our relationship with Sidra isan essential component in thefull integration of our triplemission of - excellence ineducation, research and clinicalcare,” says Dr. Sheikh.


January 2011 | 10

Arab Health 2011 PreviewThe Arab Health Exhibition andCongress is one of the region'spremier events for thehealthcare sector. At the 2010event, 2500 exhibitors from 60countries showcased productsand services with more than55,000 professionals from 145countries attending. There areexpected to be around 2700exhibitors at the 2011 event,and 30 country pavilions.

The Dubai Health Authority (DHA)will be part of the global platformwelcoming the internationalhealthcare industry to Arab Health2011. The UAE healthcare sectorhas proven robust against theglobal downward economic trendand the DHA is confident that theUAE’s healthcare sector willcontinue its growth.

The healthcare market in the GCCis expected to grow at about 9 percent annually to reach US$47billion to US$55 billion (aroundDh172 billion to Dh202 billion) by2020, said a report by AlpenCapital. More than 200 hospitalprojects have been announced orare under construction withcumulative capacity of up to 27,000beds, most of which are due to bedelivered by 2015. According thereport, the growth will be driven byboth an increase in demand innumber of treatments and the costof health care provision pertreatment.

His Excellency, Qadhi Saeed AlMurooshid, Director General of theDHA, said: “Governments are facedwith an increasing number of issuesand demands for better healthcarefrom our growing populationscontinue within an increasinglychanging economic environment.The UAE healthcare sector hasproven robust against the globaldownward economic trend and with200 hospital projects and 27,000

additional hospital beds expected tobe delivered by 2015; the UAE’shealthcare sector will continue itsgrowth. “As a strategic healthauthority, it has always been ourendeavor to provide the populationof Dubai with the very best qualityof healthcare services and we shalladhere to our commitment todevelop additional facilities,

improve the available services andto developing new focusededucational events to support andexpand the future of the healthcarein the UAE.” To remain certified,doctors must regularly update theirskills, knowledge and practicalknow-how to provide the bestservice to their patients and toensure their license to practise

Arab Health 2010


January 2011 | 12

does not lapse. For many in theGCC this represents a significantfinancial investment and time costas only limited CME (ContinuingMedical Education) accreditedcourses are available in the regionforcing practitioners to travelabroad.

Cleveland Clinic CMEaccredited conferences Arab Health also features theworld’s largest multi-track medicalcongress with 18 CME-accreditedconferences at which healthcareprofessionals can earn continuingmedical education (CME) credits.The 2011 conferences will beaddressed by around 500 speakersand host more than 5,500attendees. Sponsored by theCleveland Clinic Centre forContinuing Education, 18conferences provide CME credits.

With the launch of Arab Health2010, IIR Middle East and theCleveland Clinic’s Center forContinuing Education collaborated

to significantly expand continuingmedical education activities in theMiddle East by giving medicalprofessionals an opportunity to gainCME accreditation by attending themulti-track conference andexhibition, reducing travel costs andtime spent away from their practice.For Arab Health 2011 the number ofCME- accredited conferences hasbeen expanded to 18.

Delegates who attend will receivean accreditation certificate that canbe used towards maintaining theirannual quota of continuing medicaleducation credits, which are nownecessary to renew medicalpracticing licenses in the UAE.

“By ensuring that our conferencesare accredited and our speakersare leading experts in their fields,IIR Middle East is committed toproviding the best possible medicaleducation available in the region,”commented Simon Page, GroupDirector of Life Sciences Division,IIR Middle East.

Arab Health 2011 Preview

SEHA are the leading Congress supporter


January 2011 | 13

Exhibitor focus: Adam,Rouilly


Adam,Rouilly produce a range ofmedical training tools from brainmodels and heart models toskeletons and anatomical charts;from venipuncture training tools andinstruments to resuscitationsimulators. These training aids helphealthcare professionals perfect allmanner of essential clinical andnursing skills from suturing andinjection techniques through toresuscitation and airwaymanagement. This range of trainingsimulators, combined with the finestrange of anatomical models andaccurate, high quality anatomicalcharts, make Adam,Rouilly one ofthe foremost names in healthcareeducation.

Adam,Rouilly sells its products tomore than forty countriesthroughout the World. Their largerange of products has beenpurposely designed and developedin direct response to customers'requirements and preferences.Speaking to Middle East Hospitalon the subject of export sales in theMiddle East, Sales and MarketingManager Graham Fowler said, “Wehave a very reliable distributornetwork in the Middle East, which isa very important part of our exportmarket, and has expandedconsiderably over the past 20 yearsdue to the increased demand forskills training. In addition to thismarket there is also a requirementfor anatomical models in themedical schools at the Universities.

“Within the Middle East we sell intomany hospitals, almost exclusivelythrough our distributors within thevarious countries. We haveobtained considerable business inSaudi Arabia, Iran, Yemen andLibya, although we supply mostcountries in the area at some timein the year. We have also securedcontracts to supply AnatomicalModels to the Sultan QaboosUniversity in Muscat and theArabian Gulf University in Bahrain.

We have also seen a considerableincrease in both enquiries andbusiness from Iraq as the situationthere improves. Hopefully this willcontinue to be the case.”

Mr Fowler continued, “Thesuccess of Adam,Rouilly’sExport Sales is due to the hardwork of our dedicated salesteam. In 2009 we achieved 50%

of our total sales in exportmarkets with significant sales inthe Middle East. The advent ofClinical Skills Training inHospitals in the Middle East is amajor factor in theseachievements.“Attending Arab Health since2004 has enabled us toregularly meet many of our

Visit Adam,Rouilly at Stand 7G 59

January 2011 | 14

Arab Health 2011 Previewcustomers, and the sales reflectthe confidence our dealers havein the products, quality andservice that Adam,Rouilly offersto Healthcare Education.”One of the most popular productsmanufactured is the Venepunctureand Infusion Arm. Cast from life, themoulding of the Infusion ArmTrainer has been improved andincorporates many new featuresresulting in an extremely realisticfinish which shows a welldeveloped male left arm in finedetail. The product features aclosed blood system which is cleanto use with reduced risk of leakage

Another in demand product is theHungry Manikin. This model wasdesigned by two nutrition nurses atBirmingham Children’s Hospital todemonstrate to parents/carers thetechnique for insertion ofnasogastric and gastrostomy tubes.The model features a movableepiglottis. The model enablesparents/carers to visualise thecorrect positioning of nasogastricand gastrostomy tubes and buttonsand also practise the technique.Families have reported that TheHungry Manikin gave theminvaluable practice and increasedtheir confidence andunderstanding. The model issupplied with a nasogastric tube inan attractive carrying case.

“To simulate the look and feel of thehuman body Adam,Rouilly usematerials which have been carefullyresearched and selected by ourdevelopment team. We continuallyevaluate our models and, in co-operation with healthcareprofessionals and nursingspecialists, develop and promotenew products as medical practiceadvances”, says Mr Fowler.The other most popular productswith Adam,Rouilly customers arethe Ear Diagnostic Trainer, theDiabetic Retinopathy Trainer, andthe X-Ray Positioning Doll.

Over 90 years of experience Adam,Rouilly celebrated its 90thanniversary in 2008, having firstsupplied natural bone material andanatomical models to hospitals andmedical schools in London in 1918.

The business rapidly expanded toall areas of Great Britain and within6-7 years a flourishing exportbusiness was established. The firstPatient Simulator (The BedfordHospital Nurse Demonstration Doll)was manufactured in 1930 andcontinues to be sold to this day.

The name Adam,Rouilly isrecognised throughout the world byhealthcare professionals for themanufacture and supply of highquality medical training aids. Fromits base in Sittingbourne, Kent,Adam,Rouilly have been exporting

to customers throughout the worldfor over 75 years and have longestablished relationships with manyworld famous medical traininginstitutions, nursing colleges,hospitals and universities.

Graham Fowler at Medica 2010


January 2011 | 15

The Venepuncture and Infusion Arm

IntroductionHistorically the UAE healthcaresystem has been underfunded, theexpenditure on health as apercentage of GDP has been lowerthan in the western world; in 2007less than 3% of GDP was allocatedto health in the UAE versus 8.4% inthe UK and 15.7% in the USA(WHO report – World HealthStatistics 2010).

It could be argued that this hasbeen partly due to differentdemographics prevalent in theUAE, such as the percentage of thepopulation over 60 years old - 2%in UAE versus 18% in the USA and22% in the UK (WHO report –World Health Statistics 2010) as itis well known that healthcare costshave a tendency to be higher as theindividual grows older and henceyounger societies would requirelower percentage of their GDP to bespent on healthcare.

Nevertheless, underfunding wasreflected in sub-optimal quality ofcare in the government hospitals,with low investment in medicalfacilities, technology, medicaleducation and also poorgovernance and lack of adequateregulatory, governance andlegislative frameworks.

However, over the last 10 years orso, with the increase in populationdriven by higher life expectancy (63years in 1970 to 78 years atpresent- People facts & PopulationReference Bureau, World Bank)and increase in expatriatepopulation (c.75%-80% of the UAEpopulation), there was a realisationamongst decisions makers that theGovernment could no longer carrythe healthcare burden on its own. Itwas unsustainable for thegovernments to provide free carefor foreigners choosing to live in theUAE, particularly in a country wherethere is no direct taxation on theincome earned by individual.

The above situation pre-empted themove from a government-fundedhealthcare model to a mixedgovernment and private sectormodel.

Growth in diseases of affluenceThe other key driver of the changein the healthcare system in the UAEis the increase in the populationaffected by the commonly known“diseases of affluence”.

Increase in purchasing power, withGDP per capita increasing by 50%between 2004 and 2008 (IMF) plusan unhealthy lifestyle with lack ofexercise have contributed to somefrightening statistics: c.20% of theUAE population suffers fromdiabetes (www.diabetes.co.uk) andthere has been increase inoccurrence of cardiovasculardiseases and cancers.

Prosperity and wealth have notmeant health!All the above factors contributed tothe realization by the decisionmakers that the situation wasunsustainable over the long termand some important changes needto be implemented at differentlevels in the healthcare system:regulation, funding and provision.

Despite this change and evolutionnot being consistent across all theemirates, and in particular betweenthe two driving emirates- AbuDhabi and Dubai; one commondirective across the federation isthat the private sector has animportant role to play and thegovernment needs to ensure itsactive participation to ensure thebuilding of a sustainable qualityhealthcare system.

Abu DhabiAbu Dhabi has been at the forefrontof changes in the healthcaresystem, including changes in thegovernance and funding ofhealthcare.

GovernanceGovernance-related changes havebeen driven to separate the role ofregulator from the role of managerof hospitals. It is an acceptedconcept that governments’ roleshould be focused on monitoringand regulating the healthcaresystem rather than managinghospitals. With this purpose inmind, in December 2007, The AbuDhabi Health Services Company(SEHA) was created with theresponsibility for operational

Healthcare in the UAE at the crossroads by Nusrate IbrahimManager -Transaction and Reorganisation Services, MENA Region at Deloitte

Dubai Health Care City


January 2011 | 16

management of public hospitalsand clinics in Abu Dhabi, whileHealth Authority Abu Dhabi (HAAD)from then on taking theresponsibility solely for monitoring,regulating and enforcing ofinternational healthcare standardsfor both the public and privatehealth sector.

Governments are bettersuited to regulate rather thanmanage providersThis has been a step forward forstrengthening the governance and thetransparency of the system, thusincreasing service users’ reliance on thesystem while simultaneouslyincentivizing the private sectorparticipation in the sector.

With this is in mind, Abu Dhabistarted to promote partnershipswith the private sector; it hassubcontracted the hospitalmanagement of some large publichospitals to renowned internationalproviders: Al Rahba Hospital, AlCorniche Hospital and TawamHospital are run by John Hospkins;Shaikh Kahlifa Medical City ismanaged by Cleveland Clinic andAl Mafraq Hospital is managed byBumrungrad International Ltd.

The establishment of ImperialCollege London Diabetes Centre inAbu Dhabi in 2006 was done inpartnership with MubadalaDevelopment Company. Thetreatment at the Centre allows thehighest level of specialized patientcare from diagnosis to themanagement of all thecomplications associated withdiabetes.

In addition MubadalaHealthcare has set up apartnership with the Clevelandclinic to develop and manage a360-bed state of the art hospital– the Cleveland Clinc Abu Dhabi(USD 1.9 billion). The hospital isscheduled to open in late 2012and it is planned to be servedby Western-trained, NorthAmerican board-certified (orequivalent).

FundingIn Abu Dhabi, Health insurancerequirement was introduced in2006, and since 2007 allexpatriates residing in Abu Dhabihad to have health insuranceprovided by their employer orsponsor.

The law requires the employers toenroll their expatriate workforce intoa scheme known as Daman, whichis run with Munich re, a Germaninsurer. There are over 30 insurersin Abu Dhabi; however most ofthem are focused on the premiummarket, while Daman caters for the“basic” level cover in addition to thepremium cover.

UAE nationals enjoy freehealthcare services under aseparate insurance scheme knownas thiqa insurance scheme; thiqamembers have access to over 1600providers, including both public andprivate.

Abu Dhabi: the way forwardHAAD has a strategic plan for2010-2104, with very specificpriorities:1. Fill critical gaps in capacity andinsurance coverage2. Improve medical outcomes3. Inspect and control for quality4. Improve health professional education5. Increase emiratization of health sector6. Improve public health7. Create customer transparency

8. Pay-for-quality9. Increase private sector investment10. Be prepared for emergencies11. Automate internal processes12. Develop quality workforce and plansuccession

The above priorities reflect acommitment by the Government ofAbu Dhabi to drive forward thechanges that have already beenstarted to be implemented in thehealthcare system.

In my opinion, it also reflects thatthere has been an assessment of“problem’ areas where more workneeds to be done, particularlyaround strengthening thegovernance, measuring medicaloutcomes and linking pay forprocedures with quality.

ChallengesHowever for this vision tomaterialise, there are some specificexternal factors which are going toplay an important role:1-The ability to train and attract qualitymedical staff and then to retain 2- Mass of service users/patients(demand) 3- Ability to attract inward medicaltourism4- Set up a quality brand associatedwith Abu Dhabi providers thatconvinces both nationals andexpats not to go abroad fortreatment.


January 2011 | 17

Certainly the Abu Dhabigovernment has already madesignificant progress in setting up afunding / insurance system;however the key challenge will beto ensure sufficient demand in allthe newly built hospitals thatensures their long termsustainability.Dubai – Planned healthcareinitiatives and reforms in DubaiDubai healthcare reforms havebeen affected by the unfolding ofthe 2008 credit crisis which had an

adverse impact across theeconomy, in particular in the realestate sector with some projectsbeing shelved while others weredelayed.Dubai Health Care City (DHCC)and Dubai Biotechnology andResearch Park (Dubiotech)DHCC free zone (a USD 3billion development) wascreated to promote privateinvestment in healthcare; toprovide high quality healthcareto the residents in the UAE and

to attract medical tourism bothfrom the region and from otherparts of the globe.

The aim is to reverse the trend ofoutward medical tourism affectingthe UAE, where the Governmentspends c. USD 2 billion a yeartreating nationals abroad. Despitethe current construction delays, theDHCC has already attracted somerenowned providers in the cityincluding: Harvard Medical SchoolUniversity Hospital, Great OrmondStreet Hospital, and AmericanUniversity of Beirut Medical Centre.

DHCC on its completion isexpected to have 17 hospitals with2,325 new beds with the aim oftreating UAE residents plusattracting medical tourists.DuBiotech (free zone), MiddleEast’s first Science and BusinessPark dedicated to global LifeScience has already started toattract a number of Biotechnology,Pharmaceutical & Researchcompanies including global leaderslike Pfizer, Johnson and Johnson,Amgen, Merck Serono andGenzyme.

However, the recovery of theeconomy will dictate the progress ofthese two major projects. Theconsensus across the broadspectrum is that the vision ofmaking Dubai a preferredhealthcare destination is not inquestion, the question is the timingwhen this vision is going totransform into reality.

GovernanceComparatively to Abu Dhabi, Dubaiis running behind the healthcarereforms and it could be argued thatthere is not yet a clear distinctionbetween the regulator and theprovider.

The Dubai Health Authority is theregulator of the healthcare in Dubaiand it is also a provider ofhealthcare facilities through theDHA healthcare facilities, includingRashid Hospital, Dubai Hospital, AlWasl Hospital. On the other hand,the Centre for Healthcare Planning

Healthcare in the UAE at the crossroads cont:

Dubiotech HQ


January 2011 | 18

About the authorNusrate is a Graduate inEconomics (University ofLeicester, 1992), a QualifiedAccountant (FCCA- Fellow ofAssociation of CharteredCertified Accountants, 2003) andis also a Member of theChartered Institute for Securities& Investment (CISI) in London.

She achieved an Islamic FinanceQualification (IFQ) with theChartered Institute for Securities& Investment in London in 2009.Her key professionalassignments have focused onbusiness planning andperformance analysis, strategyevaluation and assessment ofrisks and controls and haveincluded both Private and PublicSector Organisations.

Nusrate joined the ProfessionalServices firm Deloitte in the UAEin March 2010 and since thenhas been involved in diverseprojects in the Gulf.

and Quality (DHCC) is responsiblefor regulating the healthcareinstitutions inside the DHHC. Oneof the key focuses of the DHA hasbeen to establish laws demandinginternational accreditationmandatory for all healthcarefacilities.

FundingUnlike Abu Dhabi, there is nocompulsory healthcare insurancerequirement in Dubai requiringemployers to cover expat workers.However, this is not due to the lackof commitment for such a movefrom the Government but just a timelag driven by the credit crisis.

The scheme was originally plannedto be operational from January2009, however due to the financialchallenges faced by the Emirate, itsintroduction has been delayed asthe Government could not afford toadd to the already struggling privatesector an additional overhead.Once the plan becomes effective, itwill be mandatory for every residentin Dubai to be part of the healthfunding system.

Operation of the Plan The new system will requireemployers to contribute the majorityof the funding through a flat rate tothe Health Benefits Contribution(HBC) pool, paid on behalf of theiremployees. Outpatient Care

Practices will be the key drivers ofthe new system and will beresponsible for the management ofpatient care. Every resident willhave to register with a public orprivate outpatient clinic GeneralPractitioner); they will then beissued a health card which will givethem access to essential healthcarewithin Dubai only.

The planned Dubai health fundingsystem even though similar to theAbu Dhabi system, has some keydifferences:

1. Abu Dhabi system requires theemployer/sponsor to provide healthinsurance coverage for theemployee and family, while underthe Dubai insurance scheme theemployee will have the choice ofoffering cover to the employee only2. The requirement for the residentsto register with a GeneralPractitioner and hence driving thesetting up of a potential referralsystem (based on the UK model)3. Nationals will have access to freecare but that would only be in publichospitals.

The original timings were for theDHA transition programme to becompleted by 2012 (under theoriginal assumption that it wouldhave started in January 2009) andfor the DHA health funding processfully implemented by 2015.

Final thoughtsIn December, I had the opportunity toattend the World Healthcare Congressin Abu Dhabi and I was encouraged bythe determination of the UAE toestablish itself as a reputable healthcaredestination; its pride in thedevelopments already in place and itscontinued efforts to ensure that themomentum was not lost.

I do believe in the potential for thedevelopment of a sustainablehealthcare system in the UAE,despite the current inconsistencybetween the stages of growth in thetwo key Emirates’ healthcaresystems.

However, I do think that thesuccessful accomplishment of thevision of making UAE an inboundtourism destination will require amore concerted and coordinatedeffort across the emirates to ensurethe buildup of enough demand,which is a key driver for attractinggood quality physicians andretaining them for the long term.

SEHA stand at Arab Health


January 2011 | 20

For 30 years Malem Medical havebeen manufacturing the world’sbest and largest range of EnuresisAlarms and Vibrating Watches forthe treatment and permanent cureof Nocturnal as well as DiurnalEnuresis.

Malem Enuresis Alarms(bedwetting alarms) are designedto maximize success in thetreatment and cure of bedwettingand provide a safe, efficient,economical and permanent cure forbedwetting in contrast to the shortterm relief offered by expensive andpotentially dangerous drugs.

Asked about Malem’s hopes forArab Health this year Dr HilalMalem told MEH, “Our main aim inbeing at Arab Health is to find localdistributors for our products. Ourworld famous Enuresis Alarms offerthe only safe, reliable, tried and testmethod for the treatment andpermanent cure of bedwetting at aneconomical cost. Drugs, in the formof antidiuretic hormone, if they workat all, provide a temporary reductionin the quantity and frequency ofbedwetting as long as the child isreceiving the drug. This could be foryears at a vast monthly cost thatcan be twice the cost of one of ourenuresis alarms.

“Wih our latest UniversalWireless alarm you can use upto seven transmitters, each oneof them can be attached to adifferent sensor (such asEnuresis body worn Sensor;Bed-Mat Enuresis Sensor;Pressure-Mat; and PressureRelease Mat) to help detectpatient movement and preventdangerous falling orunauthorised wondering. Onesmall battery operated receiverthat can be carried by the carerwill communicate with up toseven Transmitters. ThisUniversal wireless product isideal for nursing/care homes, orfor use at home.”

Exhibitor focus: Malem Medical

Another exciting product is theTalking Vibro-Watch. You canprogramme this watch for up totwelve (12) specific times andrecord a unique message for eachtime so that the user will bereminded at the correct time withVibration and a dedicated messagethat will be announced.

The Malem Bedwetting Alarm consistsof a safe electronic device contained ina small, ultra lightweight plastic boxwhich is comfortably and discreetly wornon the nightwear top close to the collarbone. The alarm is connected to asensor which detects urination. Whenurination commences and the sensor ismoistened, the alarm is triggered and astimulus is activated. This can be in theform of a loud sound, vibration or light.The Easy-Clip, Standard or Bed-Matsensors can all be linked to any of thealarms. Repetitive awakening by theAlarm as soon as urination commenceswill gradually train the brain to exertautomatic control over the bladder.Eventually, the bedwetter will either

wake up before urination or be curedresulting in them sleeping throughoutthe night without needing to empty thebladder. This form of treatment has proved to bethe safest, most reliable and economicalway of curing bedwetting with over 90%success within a few weeks and has noside effects. Dr Malem explains,“Bedwetting, or nocturnal enuresis, is avery common but secret problem. It isvery distressing and deserves to betreated. It can affect anyone and asmany as 10% of 5 year olds, 5% of 10year olds and 2% of adults sufferunnecessarily. As many as 40% of theelderly may also suffer fromincontinence.”

Malem Medical sell their productsall over the world. In the UK thecompany has won the NHS SupplyChain contract for supply to theNHS, giving them almost 100% ofthe UK market. They have achievedaround 80% of the market share inthe US, and are well established inEurope, Japan, Brazil and Korea.

The Talking Vibro-Watch


January 2011 | 22

Arab Health 2011 Preview

Malem Medical stand at Arab Health 2010

The Universal Wireless AlarmVisit Malem Medical at

Stand 7H 58


January 2011 | 23

Saudi Medicare 2011… YourGateway to a US$ 16.3 BillionHealthcare Market

Ranking second in appropriationsafter education, the Saudihealthcare sector had US$ 16.3billion to spend during 2010 on thedevelopment of numerous projectsthat include:- Hundreds of new primary carecenters throughout the Kingdom.- 92 new hospitals with a capacityof 17,150 beds- Three teaching hospitals withinuniversity campuses with a totalcapacity of 1800 beds.- Various hospitals and medicalscience colleges in all threeprovinces.

Pharmaceutical and healthcarespending in Saudi Arabia isexpected to increase from US$9.94 billion in 2008 to US$ 18.09billion by 2013, driven by thegrowing healthcare demand of thecountry's sizeable and relativelywealthy population. The positivegrowth trend reinforces thecountry's reputation as a keystakeholder in the regionalhealthcare industry as Saudi's drugmarket already accounts for adominating 65 per cent of allpharmaceutical sales in the GCC.

Saudi Arabia's pharmaceutical andmedical device markets, inparticular, are expected to grow ata compound annual growth rate of12% and 7% respectively until2012. This growth is influenced inpart by aggressive governmentspending as US$ 16.3 billion hasalready been allocated forhealthcare expenditure,representing a 17% increase from2009, for various large-scaleprojects including new primarycentres all over the country and 92new hospitals with a combinedcapacity of 17,150 beds. The robustoutlook of the country's healthcareand pharmaceutical sectors isevident in the upcoming 'Saudi

Demand for pharmaceuticalproducts as well as medicalsupplies and related services haspicked up on account of the SaudiGovernment's efforts to strengthenthe country's ability to provideworld-class healthcare to itscitizens and residents. Thegovernment has even increasedhealthcare expenditure this year toensure that upgrade programs areimplemented immediately. Globaland regional companies have

Medicare 2011 – The 14thInternational Healthcare, HospitalSupplies and Medical EquipmentShow', which will be held from April10 to 13, 2011 at the RiyadhInternational Exhibition Center.Saudi Medicare 2011 hasregistered a 30% increase inexhibition area to accommodate asignificant rise in exhibitors andtrade visitors, including a growingnumber of corporate decisionmakers of healthcare multinationalsand foreign investors.

SAUDI MEDICARE 2011: Preview

April 10-13 2011 at the RiyadhInternational Exhibition Center


January 2011 | 24

“The substantial growth in theSaudi healthcare sector isunmatched anywhere else in theGulf region and across the entireMiddle East. The Saudigovernment has set ambitiousgoals to trigger massivedevelopment of the sector bylarge budget allocations thatreached $US 16.3 billion in 2010.The 9th five year plan announcedby the Saudi Council of Ministerslast August, and which includesinfrastructure and welfareprojects valued at US$ 385 billionplanned for the period 2010 –2014, calls for the construction of117 new hospitals including 32specialist ones with a totalcapacity of 22,372 beds. Theplan also calls for theconstruction of 750 primary carecenters and 400 first aid centersduring that period.”“We strongly believe that SaudiMedicare 2011 will be anexceptionally important edition forall international manufacturersand suppliers of healthcaretechnologies and medicalequipment and supplies and anideal platform to tap into thislucrative and dynamic market.The full support Saudi Medicareenjoys from the Saudi Ministry ofHealth, adds further assurancethat the show will be attended atthe highest level by top industryprofessionals and publichealthcare authorities in theKingdom”

Fadi Kaddoura, Group VicePresident, IFP Group / Riyadh

Abdullah Al Thari of the Saudi Ministry of Health (Director of Equipment& Supplies Directorate), and Fadi Kaddoura, (Group Vice President, IFPGroup / Riyadh Exhibitions Co.) visited the Medica trade fair inDusseldorf to introduce the upcoming Saudi Medicare 2011 trade showto the global healthcare community.

During their visit to Medica Mr Al Thari and Mr Kaddoura officiallyannounced the opening of nominations for the Middle East HospitalHealth and Innovation 2010 awards, with the winners to be presentedwith their awards at Saudi Medicare by the Saudi Minister of Health, Dr.Abdullah bin Abdul Aziz Al Rabeeah. The distinguished visitors alsovisited the UK Pavilion and met exhibitors looking to export to thebooming Saudi healthcare market.

Jonathan Richards CEO of Medibord meets Abdullah Al Thari Saudi Ministry of Health –Director of Equipment & Supplies Directorate and Fadi Kaddoura VP Riyadh Exhibitions

responded promptly as manifestedby the significant increase in thenumber of exhibitors who are on thelookout for lucrative business andinvestment opportunities in thecountry.Saudi Medicare has furtherrevealed that it expects 2011 toserve as a starting point of a newera of growth in the country'shealthcare industry with newbusiness opportunities emerging in

medical devices and supplies,generic pharmaceuticals,healthcare insurance andeducation. Saudi Medicare alsonoted a huge potential in therelatively new area of e-health,which has received a majorboost with the government'sefforts to establish a nationalelectronic record system forhealthcare.

Held concurrently with SAUDIMEDICARE 2011 are SAUDIDENTISTRY, SAUDI EYECAREand SAUDI LAB 2011. This 4 in1 show will facilitate directaccess to key governmentofficials, healthcare sectormarket leaders, investors,importers, and fellowprofessionals. Such an

invaluable exposure willundoubtedly help you inestablishing a foothold in thisvibrant market and will enableyou to present your products,technologies, and services to ahighly professional audienceeager to examine the latestmedical innovations.

Saudi Medicare 2011 will be held aswell in conjunction with the 5thMedical Devices Scientific Forum,which is organised in cooperationwith the Saudi Food and DrugAuthority. The scientific forum willdiscuss various topical medicalissues, including those related tomedical devices technology, itsmanagement, and the challengesbeing faced in this field of expertise.www.recexpo.com


January 2011 | 25

For 24 years Dr. Abdulrahman AlMishari Hospital has been providinghigh quality of Medical Care to itspatients. It has dedicated its time toensure that an evidence basedstandard of Health Care is achievedand rendered to our patients andtheir families.

The hospital strives to protect andcontinuously improve theenvironment, by maintaining a caremanagement procedure preparedfor any situation that may affect theresidents of our Community. Thehospital is a Private GeneralHospital comprising of 122 beds.

Mohammed Al Mishari, VicePresident of the hospital spoke toMEH about the hospital and itsfacilities, «The ARMH recently

installed a state of the art, 16 pro-slice CT Scanner. The newscanner enables enhanced cardiacand paediatric scanning services. Italso houses a static MRI Unit, amuch prized clinical development.»

Asked about internationalrecognition Mr Al Mishari said, «Weare very pleased to inform you thatafter all the hard work and efforts ofour beloved staff, in July 2010 Dr.Abdulrahman Al-Mishari Hospitalhas passed the Re-AccreditationProcess and received the highestaward – Diamond Accreditation bythe Accreditation Canada.

«Dr. Abdulrahman Al-MishariHospital is the first hospital in theMiddle East who had beenaccredited by the Accreditation

Canada, new QmentumInternational Program.

«The organization received“Qmentum International ofAccreditation Canada” for focusingon the achievement of quality, bymonitoring outcomes, by usingevidence, by working on the bestpractice to improve services, andby benchmarking with peerorganizations to drive system-levelimprovements».

In further recognition of itsachievements the hospital has nowbeen nominated for an MEH awardfor oustanding services tohealthcare in the Middle East.Looking ahead to the future Mr AlMishari said, «We are currentlygathering information from the

Dr Abdulrahman Al Mishari Hospital


January 2011 | 26

community and the public duringthe next few months and then planto release a strategic plan for a 5-year period starting next year.

«Despite the global slowdown,Saudi Healthcare industry isbooming, as well as the HealthInsurance industry. We do haveplans for domestic expansion, andGod willing, to go international inthe near future.»

History of the hospitalIt was in 1972 that the youngAbdulrahman fulfilled his one bigdream. He graduated and becamethe very first physician from theeastern province. He became thefirst Saudi Member of the RoyalCollege of Obstetrics andGynaecology in London.

Upon returning home, the Saudigovernment recognized andhonored Dr. Mishari for hisachievements. They saw in him thecapability to run and supervise theconstruction of the very first Collegeof Medicine in the Kingdom ofSaudi Arabia intended to cater tothe educational and professionalneeds of the young nation.

It was in 1980 that Dr. AbdulrahmanAl Mishari was appointed DeputyManager and Head of theGynaecology Department in KingKhaled University Hospital. As theKingdom was developing rapidly,the University Hospital and MedicalSchool was set for massiveexpansion and the responsibility asProject Manager to oversee thedesign and construction of theCollege of Medicine was given toDr. Mishari. Under his leadership,a modern school for College ofMedicine was built and more than500 Saudi nationals graduated andbecame new doctors.

After long years of a dedicatedteaching career, Dr. Misharidecided to pursue his other dream– contribute to the development &infrastructure of the fast growingeconomy, by establishing a privatehospital. In Year 1987, the Hospitalwas inaugurated with the Governor

of Riyadh Region, His RoyalHighness Prince Salman BinAbdulaziz Al Saud, doing thehonor of cutting the ribbon.Today, together with hischildren, Hadeel andMohammed, Dr. Abdulrahman Al

Mishari’s journey continues.Their quest for quality andservice excellence is relentless,through good leadership andpassion for quality.

[email protected]


January 2011 | 27

MEH 2010 Health and Innovation Awards

Medibord Ltd have launched the world’sfirst fully x-ray translucent and non-conductive material for a range of couchtops and patient positioning devices.Medibord™ is a unique and innovative MRI,CT and radiotherapy compatible material.Unlike carbon fibre alternatives, Medibordhas been designed to be fully x-raytranslucent and non-conductive ensuring noheating occurs with MRI giving no artefactsand enabling accurate software imageoverlay. Successful clinical trials carried outby the British Healthcare Service at theNottingham University Hospitals haveproved the Medibord™ to be a revolutionarymaterial for the use in radiotherapy and MRIscans and treatment.

Since the opening of nominationsfor our 2010 Healthcare andInnovation Awards for exporters ofmedical equipment to the MiddleEast, and healthcare providers,there has been a high number ofapplications from companies andhealthcare providers from all areasof the industry.

The awards are now in theirsecond year, as is the magazine.The 2009 awards were presentedat Arab Health 2010 by Lord Darzi,the distinguished surgeon and UKbusiness ambassador. This year, inrecognition of the importance of theSaudi Arabian healthcare market toexporters to the region (the largestmarket in the Middle East) thewinners will be presented with theirawards at Saudi Medicare 2011 bythe Saudi Health Minister. Also, atArab Health 2011 Lord Darzi willpresent official nominations tosome of the UK-based nominees.The awards categories covermanufacturers and providers ofhospital equipment, nursingequipment, respiratory devices,preventative solutions, surgicalequipment, and more. Newproducts for export to the Middle

played a major role in the ongoingrevolution in healthcare provision takingplace in the Middle East.

Nominations must be completed by 28February 2011. Please visit the MEHwebsite www.middleeasthospital.com tofind out how to put your product,company, or organisation forwardfor an award.

East are being recognized, as wellas established products that havealready made a significantcontribution to healthcare in theregion.

There is also a section for the bestexporters from the most prolificexporting regions and countries,and awards for hospitals,companies or individuals that havemade outstanding contributions tohealthcare in the Middle Eastregion with awards for excellence inpediatric care, cardiovascular care,orthopedic care, rehabilitative care,respiratory care, cancer care,healthcare recruitment, andhealthcare research. These awardsare intended to recognise thecontribution of companies fromacross the globe to healthcareservices in the Middle East, and thebenefits their products haveprovided for hospitals, cliniciansand patients in the region.

The Arab countries import the vastmajority of their medical devices andhealthcare products, and theintroduction of high quality, innovativenew technologies to these countries bymedical equipment manufacturers has

Most innovative product for export: diagnostic categoryMedibord Limited for the Medibord MRI, CT and radiotherapy compatible material


Lord Darzi (left) with Adrian Cossorof AC Cossor at Medica. LordDarzi will present UK companieswith MEH award nominations on24th January at 5pm in the Novotelat Arab Health 2011

January 2011 | 28

Official Nomineefor 2010 Awards

MEH

201

0 Health and Innovation

Adam, Rouilly produce a range ofmedical training tools from brain modelsand heart models to skeletons andanatomical charts; from venipuncturetraining tools and instruments toresuscitation simulators.

These training aids help healthcareprofessionals perfect all manner ofessential clinical and nursing skills fromsuturing and injection techniques throughto resuscitation and airway management.

This range of training simulators,combined with the finest range ofanatomical models and accurate, highquality anatomical charts, make Adam,Rouilly one of the foremost names inhealthcare education.

Outstanding contribution to healthcare in the Middle East: educational categoryAdam, Rouilly for the Hungry Manikin

Award for excellence inrespiratory careMichael Oko

Michael Oko is a dedicatedENT (Ear, Nose & Throat)Consultant surgeon with aspecial interest in both sleepapnoea and snoring,campaigning for better researchand facilities for sufferers ofthese conditions, including therisks associated withundiagnosed sleep apnoea.

In 2005 Mr. Oko was appointedas a consultant surgeon for ENTfor the United LincolnshireHospitals Trust, and then as theClinical Lead (head ofdepartment) in 2007. This ledhim to set up the sleep servicewithin the Lincolnshire County,ensuring that people within thearea had access to such anecessary facility that waspreviously lacking.

In 2006 Michael Oko foundedthe Snoring Disorders Centreto develop except ionalservices to pat ients for thediagnosis and t reatment o fobstruct ive s leep apnoea.

For 30 years Malem Medicalhave been manufacturing theworld’s best and largest rangeof Enuresis Alarms andVibrating Watches for thetreatment and permanent cureof Nocturnal as well as DiurnalEnuresis.

Malem Enuresis Alarms(bedwetting alarms) are designedto maximize success in thetreatment and cure of bedwettingand provide a safe, efficient,

economical and permanent cure forbedwetting in contrast to the shortterm relief offered by expensive andpotentially dangerous drugs.

With the new Universal Wirelessalarm you can use up to seventransmitters, each one of them canbe attached to a different sensor tohelp detect patient movement andprevent dangerous falling orunauthorised wondering. Thisproduct is ideal for nursing/carehomes, or for use at home.

Most innovative product for export: nursing categoryMalem Medical for the Universal Wireless Alarm


January 2011 | 29


MEH

201



MEH

201


Most innovative product for export: preventative categoryBedfont Scientific for the NObreath FENO monitor

Established in 1976, Bedfont ScientificLimited specialises in the manufactureof exhaled breath and gas monitoringinstruments for medical, scientific andindustrial markets throughout the world.

Applications include carbon monoxidemonitors for use in smoking cessationprogrammes (Smokerlyzer®) and bythe emergency services for carbonmonoxide poisoning (toxCO™);fractional exhaled nitric oxide (FENO)detection to provide accurate analysis ofairway inflammation (NObreath®),breath hydrogen monitoring to aid thedetection of gastrointestinal disorders(Gastro+ Gastrolyzer®) and a medicalgas delivery system used in inhalednitric oxide therapy for hypoxic neonatesand pulmonary hypertension(NOxBOX®).

Bedfont also strives to produce highquality consumables at the lowestpossible prices; these includedisposable cardboard mouthpieces,infection control filters, non-alcoholwipes and calibration gas for all theirmonitors.

Durbin PLC is a specialistmedical supply company thatsources and distributes medicalequipment, pharmaceuticalsand consumable supplies tohealthcare professionals in over180 countries.

Established in 1963 in Londonand with an expected turnoverin excess of £40m this year,they have set up their operationto act as a one-stop-shop ableto deal with healthcare supplyneeds from local project level tonational scale projects.

In addition to the exportbusiness, they have divisionsthat handle clinical trialsupplies, imported medicines,and family planning supplies.They also handle storage anddistribution for a number ofthird-parties.

Nominee for British-MiddleEast exporter of the year 2010Durbin PLC

Outstanding contribution to healthcarein the Middle East: ancillary categoryTTC Language Services Ltd forPharmaceutical translation services

TTC provides pharmaceuticaltranslations by specialised translatorswho have experience working with thepharmaceutical industry. Currently, TTCprovides translation services forsuppliers of turnkey pharmaceuticalplants; machinery and equipment for thetreatment of pharmaceutical rawmaterials; analytical instruments and labreagents; testing instruments; activepharmaceutical ingredients; tabletingand capsulation unit.

TTC are equipped with 16 years ofexperience in the fields of translationand localisation, a solid infrastructure ofproviding comprehensive languageservices and most importantly a clearvision. They have now provedthemselves as a leading languageservices provider for both online andoffline media and for local and globalrequirements.


MEH

201



January 2011 | 30


MEH

201


www.drabdulrahmanalmishari.com.sa


MEH

201


MISSION STATEMENT

Dr. Abdul Rahman Al-Mishari Hospital

is committed to Superior Quality and Safety in meeting the

Health care needs of the clients we serve by Fostering Advanced

and Compassionate Health care Services.

VISION STATEMENT

We shall treat each patient like a member of our own family

thus providing Superior Quality Health care Services and to be

recognized as the center of excellence in the Management of

Obstetrics, Gynecology and Pediatrics in the Central Region

of Kingdom of Saudi Arabia.

For 24 years Dr. Abdulrahman Al Mishari Hospital has been providing high quality of Medical Care to its patients.

earor 24 yFviding high quality of Medical Caropr

Abdulrahman .s Drearviding high quality of Medical Car

Al MisharAbdulrahman e to its patients.viding high quality of Medical Car

i Hospital has been Al Mishare to its patients.

i Hospital has been e to its patients.

Key Contributions From: Dr. Ajit Nagpal, Former Advisor Health Policy and Hospital Affairs, Ministry of Health, UAE

Dr. Michael Bitzer, CEO, National Health Insurance Company, Daman

Dr. Finn Goldner, Manager Health Insurance Regulation, Health Authority Abu Dhabi

Dr. Philipp Vetter, Head of Strategy, Health Authority Abu Dhabi

Dr. Haidar Al Yousuf, Director of the Funding Department, Dubai Health Authority

Topics being discussed include:

market in the GCC

stakeholders

6th Healthcare Insurance Forum aims to provide

latest updates and insights into healthcare insurance

spread of compulsory healthcare insurance around the reason, and case studies from international healthcare insurance markets.

www.iirme.com/healthcareinsurance

Mention code: MH-HI and save 15% off of regular fee.

latest updates and insights into healthcar

6th H

latest updates and insights into healthcar

Healthcare Insurance

e insurance latest updates and insights into healthcar

ovid aims to pr Forum

e insurance

e

insurance markets. eason, and case studies frr

ead of compulsory healthcarspr

insurance markets. om intereason, and case studies fr

ead of compulsory healthcar

national healthcarom interound the e insurance aread of compulsory healthcar

e national healthcaround the




Bolton Surgical Ltd is a manufacturerand supplier of the finest quality SurgicalInstruments and accessories for usewithin the modern theatre environment.The company has a large customerbase of both NHS and private sectorhospitals, clinics, and DecontaminationUnits throughout the UK.

Bolton bring together traditionalmanufacturing methods with thetechnology you would expect from amarket leader in Surgical Instrumentsupply, enabling them to provide a totallyflexible service tailored to meet thediffering and demanding needs ofmodern Theatre/DecontaminationDepartments.

Outstanding contribution to healthcare in the Middle East: surgical categoryBolton Surgical for their range of surgical instruments

The goal of TRUMPF MedicalSystems is to improve processesin clinics and to make workingconditions there more ergonomic.TRUMPF offers operating tables,surgical lights and ceiling-mountedequipment management systems.

In all business areas, innovationsfrom TRUMPF are setting newtrends and they are establishing

2010 German-Middle East expoter of the yearTRUMPF Medical Systems


new technical standards. Thecompany's innovative strength isderived from high ex¬penditures onresearch and development, whichis 9.7 percent of sales (fiscal year2009/10).

The TRUMPF Group has itsheadquarters in Ditzingen,located near Stuttgart,Germany.

Olberon Medical Innovations Limited, is a privately-ownedUK company, based at the University Of NottinghamInstitute for Enterprise and Innovation Lab. As a start-upcompany, Olberon was formed in Summer 2005, in order todevelop and commercialise innovative medical devicesconcepts that originated from direct experience of patientcare, where the need is clearly identified and the solution’sintellectual property rights are closely protected. Pivotal toOlberon is its I.P., and the experience of its managementteam.

Vacuderm is a cannulation dressing with a disposable vein inflationaid attached to distend the vein prior to needle insertion, ideal forknown problem patient groups such as paediatrics, obese, illegaldrug users, chemotherapy patients etc. and for improvingcannulation success in general.

Most innovative product for export: nursing categoryOlberon for the Vacuderm cannulation dressing

January 2011 | 32


MEH

201



MEH

201


UK strengthens its commitmentto the UAEWith the UK famous internationallyfor its world leading, dependableand top quality healthcare products,Arab Health 2011 will be a busy fourdays for over two hundred Britishcompanies travelling to the event.

The UK’s interest in internationaltrade is at an all time high, and ArabHealth allows companies to exploreexciting export opportunities andshowcase their world leadingtechnologies on a global stage.Home to world class scientificexcellence and innovation, the UKcontinues to be committed totransforming healthcare deliverythrough investment in science andtechnology.

The UK already enjoys an excellentrelationship across the Middle East,with British companies supportingUAE health delivery reforms byoffering a wide range of first ratemedical technologies andmedicines. For this reason, it is nosurprise that the UK’s presence atArab Health is considerable andgrowing each year exploring exportopportunities on an internationalstage.

RD Biomed will be at the show tolaunch their product Peptest™ arevolutionary diagnostic device thatdetects reflux disease more quicklyand easily by measuring the level ofpepsin in clinical samples .Single Use Surgical will also travelto the event to speak to potentialpartners from across the UAE ontheir single use instruments.

Promoting the concept of ‘daysurgery’ in the Middle East, AneticAid will be at the show to explainhow modernising approaches tosurgical procedures can reducewaiting times, improve costefficiency and make health servicesmore patient-centred.

Recently awarded The Queen’sAward for their innovative

huge problems with samplespecimen collection and point ofcare testing, Brenmoor Ltd offer asolution to this global problem withtheir printed wristbands andidentification scanner and printer.

Merlin Medical is also travelling toDubai to seek new businesspartners from across the UAE. As aone-stop-shop of cutting edgeinnovations, including manualresuscitators, infection controlproducts and medical supplies forthe emergency services.

A world leader in assistivetechnologies and offer an extensiverange of innovative mobilityproducts, Drive Medical will be atthe show with examples of theirwheelchairs, mobility scooters,powerchairs, daily living aids andrise and recline armchairs.

All of the examples above highlightthe outstanding standard of UKinnovation and in these globallytesting times, it is vital thatcompanies keep striving for thelatest advances in technology andpatient care.

For more information on any of thecompanies visit them in Hall 7stand D37 or contact Victoria Haleyat [email protected]

JRI Ltd hips and shouldersPaxman cooling system

orthopaedic products, JRI Ltd istravelling to Arab Health next monthto offer their surgical solutions to aworldwide audience; showcasingtheir range of primary and revisionhips and shoulders.

Offering their pressure relieving andpressure reducing equipment to theMiddle East, Park HouseHealthcare will be at the showproviding their innovative solutionsin pressure area care, posturalmanagement and moving andhandling and act as a launch padfor their lightweight, durable, easyto manoeuvre aluminium hoists.

Inditherm plc is at the show tounveil their safe and practicalsolution for nursing new bornbabies across the region. CosyCribprovides the perfect environment tokeep new born infants warm andcontent during their stay in hospital.

Showcasing their range of vitaminsat the show Principle Healthcareis one of the UKs leading vitamin,minerals and supplementsproducers and are hoping to meetdistributors from across the world.

Every day thousands of patient’ssamples are lost, mislay or mixedup due to human hand writingerrors – an issue that is causing

Arab Health 2011 Preview: UK Pavilion


January 2011 | 33


Mirage, as a brand, has beenrepresenting high quality medicaland dental innovations for over 15years and was subject to an MBOin 2003 by current ManagingDirector Jeremy Bishop. The Groupis comprised of Mirage Medex, andits dental arm, Mirage DentalProducts Ltd.

Mirage Medex specialises in theprovision of ear care productswhich allow clinicians to carry outsafe and effective ear care inaccordance with today's UKguidelines in primary care and ENTsettings. The unique Propulse earirrigation range has been suppliedto the UK primary care market since1997. Mirage also exports its rangeof products to Europe, South Africa,Australia, and the United States.

The Propulse Ear Irrigator has beenthe clinicians choice for over 10years. Over that time, the marketleading Propulse range of productshas developed to include goodvalue, high quality instrumentsdesigned specifically for ear care.The current range includes thePropulse NG Ear Irrigator thatutilises Propulse Single Use QrXTips (to help minimise the risk ofcross infection between patients).Propulse Cleaning Tablets ensurethat the cleaning of the PropulseEar Irrigator is a simple andeffective procedure. The PropulseNG was launched in January 09and encompassed focus group anduser feedback culminating in themost up to date, user and patientfriendly Ear Irrigator to date.

David Caldwell, General Manager –Sales and Operations, told MiddleEast Hospital, “Mirage Medex iscommitted to continually workingwith clinicians to provide the toolsthey need to carry out safe and

succesful ear care for patients. Wehave strong links with the variousUK bodies responsible for carryingout nurse ear care training andissuing UK guidelines andprotocols. We use this as a route tocontinually gain feedback fromusers of our products. In additionwe carried out a national ear caresurvey in 2007, targeting everysurgery in the UK to identify trendsin ear care and areas for futuredevelopment, which culminated inthe January 09 launch of thePropulse NG.”

In 2009 the Propulse NG, the latestin an impressive range of ear careproducts from Mirage HealthGroup, won a Middle East Hospital

Health and Innovation Award in theMost Innovative PreventativeTechnology Product for Exportcategory.

The Propulse NG IrrigationSystemThe Propulse® NG sets newstandards in ear irrigation. Itspatented and unique featurescreate an irrigation system that issafe, convenient and patientfriendly. The Propulse®NGIrrigation System is both portableand rechargeable making it ideal fordomiciliary visits or in areas withoutan electricity supply. Its variablepressure delivery system providesa pulsed water jet, which is easilycontrolled.

Exhibitor focus: Mirage Health Group

The Propulse ProScoop

January 2011 | 34

The Propulse® NG Electronic EarIrrigator is now supplied with the allnew, patented Quick ReleaseHandle and QrX™ Single-Use Tips.The QrX™ system locks the tip intoplace during use, making this themost operator- friendly Propulse®to date. The operation of thePropulse® NG is controlled by theconvenient footswitch, allowing themachine to be controlled by thefoot, leaving both hands free fortreatment of the ear. A full range ofaccessories and consumable itemssuch as Single Use QrX™ Tips and

Propulse Cleaning Tablets isavailable for use with the PropulseNG. The Propulse NG is a class IIaMedical device manufactured inaccordance with the MedicalDevice Directive 93/42/EEC and isCE marked for safety.

New products being launched atArab HealthJoining the ever expanding Propulse®family of ear care products MirageHealth Group are pleased to launch thePropulse® ProScoop and thePropulse® ProTect Shoulder Cape, withdeliveries commencing January 2011.

Designed specifically for theremoval of ear wax and not anadapted surgical instrument, theProScoop is single use, for reducedrisk of infection. A Miragespokesman says, “The benefits fordistributors of both new products isthat the Propulse® brand issynonymous with quality ear careproducts, and Mirage is runningadvertising campaign fromNovember 2010 to January 2011targeting practice nurses, creatingnew product awareness.“The ProTect’s 3 ply design

combines a super absorbent papermaterial with a waterproof backing layerto provide maximum protection - theabsorbent paper material helps preventwater “run-off” whilst the waterproofbacking helps protect the patient’sclothes from splashes and spills duringthe ear irrigation procedure.”

The ProScoop has already been nominatedfor an MEH Health and Innovation Award forMost Innovative New Product for Export in theENT category. www.miragehealthgroup.com

The Propulse® NG Electronic Ear Irrigator

Visit Mirage Health Group atStand 8A 50

January 2011 | 35

Obstructive Sleep ApneaOSA affects 4% of adults worldwide, but is often not diagnosed ortreated. A new online survey conducted by Philips HealthcareMiddle East indicates higher prevalence of the condition in the UAE


January 2011 | 36

Obstructive Sleep Apnea (OSA) isone of the most common sleepdisorders worldwide. It is acondition that causes a person’sbreathing to stop repeatedly duringthe night, causing disruption in theirsleep as they struggle to breathe.As a result, they never get thedeep, restorative sleep that isneeded. OSA can not onlynegatively impact a person’s overallquality of life and productivity, but itcan also potentially lead to serioushealth issues like increasing the riskof type 2 diabetes, high bloodpressure, abnormal heart rhythm,strokes and other conditions.

Individuals with moderate to severeOSA often have a number ofsymptoms including loud, disruptivesnoring, gasping for air or chokingduring sleep, and excessivedaytime sleepiness. OSA can easilybe diagnosed by physicians uponassessing a patient’s complaintsand symptoms. If sleep apnea issuspected, a patient will be referredfor a diagnostic sleep study knownas a polysomnogram (PSG), toconfirm the type and severity of thesleep apnea, as well as theappropriate treatment.

Survey indicates higher prevalencelevel of OSA in the UAEPhilips conducted an online SleepApnea Awareness campaign titled‘Do You Snore’, to help build publicconsciousness about ObstructiveSleep Apnea (OSA) in the UAE.Email invitations were sent out to fillout a short and straight forwardsurvey to more than 20,000recipients based in the country,targeting a sample group of the age25 and above.

Almost 6% of respondents showedpositive results and are very likelyto be suffering from OSA. Thepotential patients were advised toprint their report and seek furthermedical advice and diagnostic testsfor sleep apnea.

Philips hosted the ‘2nd Gulf SleepApnea Meeting’ on the 16th ofDecember, inviting sleep medicine

clinicians from around the Gulf andMiddle East to discuss the survey’soutcome and give deeper insightson topics related to sleep apneasuch as Obstructive Sleep Apnea(OSA) and CardiovascularDiseases, Sleep and Aging, as wellas showcasing the latest solutionsin OSA Therapy Systems.

"Obstructive Sleep Apnea is themost common form of sleep-disordered breathing, affectingapproximately 2% of women and4% of men, globally. A largeproportion of cases remainundiagnosed”, said Diederik Zeven,Senior Director and GeneralManager of Philips HealthcareMiddle East. “Most people fail toseek medical diagnosis for this

most common form of sleepdisorder breathing. Treating OSAcan limit the risk of developing thelife-threatening conditionsmentioned earlier and improvequality of life”, he adds.

Open airway

Obstructed airway


January 2011 | 37

“Philips Respironics is theinternational market leader,designer and manufacturer ofSleep Therapy Solutions. As aleader in the sleep market and thetreatment of OSA, we design sleeptherapy products that should helpsimplify healthcare providers’ work.Recently; we released an intelligentSleep Therapy System to treatObstructive Sleep Apnea (OSA).This new system represents thestate of the art technology in thetreatment of OSA”, said Mr Zeven,“It is a Continuous Positive AirwayPressure (CPAP) solution withintelligent technology that simplifiespatient management by treatinginstead of monitoring patients andrecognizing when therapy needsare changing, while offeringsophisticated comfortenhancements.”

The vast majority of people fail toseek medical diagnosis for sleepdisordered breathing. Individualswith moderate to severe OSA oftenhave a number of symptomsincluding loud, disruptive snoring,gasping for air or choking during

sleep, and excessive daytimesleepiness. However, only afraction of such people have beendiagnosed.

OSA can easily be diagnosed byphysicians upon assessing apatient’s complaints and symptoms.If sleep apnea is suspected, apatient will be referred for adiagnostic sleep study known as apolysomnogram (PSG), to confirmthe type and severity of the sleepapnea, as well as the appropriatetreatment.

Once OSA is diagnosed as thecause of a patient’s complaints andsymptoms, it usually can beeffectively treated with CPAPtherapy, a non-invasive approachwhich is the standard treatment ofchoice for OSA. CPAP provides agentle flow of air pressure throughthe nasal passage using a mask,preventing airway collapse to allowan OSA patient to breathe freelyduring sleep. The CPAP device isequipped with various features toincrease patient comfort duringtherapy.


January 2011 | 38

SLEEP APNOEAVITALITY FOR LIFE


MEH

201

0 Health and [email protected]

Looking for Healthcare Partners in the region

Visit us at STAND 7E14

[email protected]

[email protected]

Looking for Healthcar

Looking for Healthcar

isit us at STV

e Partners in the rLooking for Healthcar

AND 7us at STTA

egione Partners in the r

AND 7E14

Like most people with obstructive sleepapnea (OSA), my diagnosis was theresult of a loved one telling me about mysnoring. While I was visiting my parents,I fell asleep watching TV. My Mom wokeme and told me I was sleeping andsnoring loudly. Of course I told her Iwasn't. This went on for a year or so.When I visited my parents again, myMom asked me if I had told my doctor Isnored? I told her no.

Finally I decided to tell my primarycare doctor that my Mom told me Isnored. He gave me a referral for asleep study. My neck size is largerthan 17 inches; I am overweight;my sister has Sleep Apnea; and Ihave Type 2 Diabetes. With allthese classic symptoms, I fit thetypical profile of someonediagnosed with Sleep Apnea.

I still can't figure out why, with all theclassic symptoms of OSA that myPrimary Care Physician (PCP)didn't refer me for a sleep studysooner, besides not knowing Isnored. He DID know I had all theclassic symptoms (he just didn'tknow I snored). Once I informedhim of that, he put it with everythinghe already knew and referred me toa sleep study. I strongly suggestthat if someone tells you that yousnore, that you let your PrimaryCare Physician know ASAP.

Getting DiagnosedMy sleep study was done on May 6,2001. The sleep study techniciantold me that if the monitoringindicated that I had sleep apneathat he would wake me up and puta CPAP on me. (CPAP is anacronym for Continuous PositiveAirway Pressure. The CPAPmachine delivers pressurized airthrough tubing and a mask. Thepressurized air acts as an air splintto hold open the airway while thepatient sleeps.) Part way throughthe sleep study the technician didwake me up and put me on a CPAP.I slept GREAT...in fact it was thebest sleep I had remembered in along time.

The next morning the technicianwoke me at 6:00 AM and the studywas over. I "unofficially" knew I hadSleep Apnea; however, before apatient can get a CPAP to bringhome, the Sleep Doctor needs to"diagnose you", which in mostcases is just reviewing what thetechnician did and writing it up.

I Want My CPAPSince I now at least "unofficially"knew I had sleep apnea, I wanted aCPAP. For whatever reason, it tookthe sleep lab A MONTH to"officially" diagnose me. Since Ihave an HMO, the results went tomy Primary Care Physician. Oncemy PCP had the results, he wrote aprescription for a CPAP, but due toHMO red tape, it needed HMOapproval. The process of getting theHMO approval took a week. While Iwas waiting for the official results ofthe sleep study, I surfed the Internetand started researching SleepApnea. I found a site that soldCPAP equipment and saw variousCPAP machines and masks. Theyhad a link to the TalkAboutSleepwebsite, which is THE BESTwebsite that I've found.

By the time I was officiallydiagnosed with Sleep Apnea, I hadhad a whole month to research thevarious CPAP machines andmasks. My DME (Durable MedicalEquipment provider -- homehealthcare company) told me Ineeded a humidifier and he gaveme one although I didn't yet have aprescription for it. I called myPrimary Care Physician and had aprescription faxed over, which tooktwo weeks.

My Primary Care Physician had writtenthe prescription for a GoldSeal mask,since that is what was used in my sleepstudy, but did sign the prescriptionwhere patient selection is permitted. MyDME said that most people have goodluck with the Breeze Nasal Pillows andthe Breeze Nasal Pillows were alsotalked about in a Talk About Sleep onlinechat, so I took his advice and got it.

Thanks to an online discussion, I havea backup DC power supply for myCPAP, so that when the power goes out,I can plug my CPAP into the DC powersupply. I ended up getting Instant Power,sold at Sears for around $70 and got theDC power cable for my CPAP from myDurable Medical Equipment store. Notethat not all CPAP machines have DCPower, in which case you have to get aninverter. I want to sleep with my CPAPeven if I don't have electricity. I waswithout electricity 48 hours this pastwinter when an ice storm took the powerout. The Instant Power has a secondarypurpose, which is to be in my truck, incase my battery doesn't turn over. It hasjumper cables on it, so I can jump-startmy truck.

Feeling Great!It's been a little over a month since Istarted using a CPAP and I have beensleeping MUCH better and will not sleepwithout my CPAP machine. It hasenabled me to watch TV shows and notfall asleep. I also feel like I have moreenergy and walked to the store (a five toten minute walk one way) whereasbefore I would have driven my truck.

Since using the CPAP I feel like Ihave MUCH more energy! I havestarted walking on Saturday's. Thetrick is to leave my apartment intime, so that I will be home prior to9:30 AM (at least in the summer)when the temperature often ishigher than 100 degrees.

Prior to using the CPAP, I use to wakeup around 3 AM every morning to go tothe bathroom, then I would getsomething to eat. This led to weightgain. Since being on the CPAP I nolonger wake up at 3 AM. The last time Iwent to the doctor, his nurse told me Ilost two pounds. I hope the weight losscontinues. My blood pressure is lower,and my doctor and I are watching it.Hopefully at some time I in the future I'llbe able to get off of the hypertensionmedication all together.

Case study provided by PhilipsHealthcare

Case Study - Bill's Sleep Apnea Story


January 2011 | 40

are the group most commonlypresent in the clinics, with a historyof loud snoring and fatigue.

Mr Oko told MEH, “The treatment ofthis condition can have a profoundeffect on transforming the quality ofpatients lives, and can be treated ata very reasonable cost. Also, due tothe strong link between OSA androad traffic accidents (RTA) thereare huge societal benefits of bothraising awareness and treatment ofthe condition.

“It is suspected that about 20% ofcar accidents are thought to besleep related and research hasshow that it can impair driving morethan drink. Indeed patients withOSA have a 7-12 fold chance of aroad traffic accident (RTA)compared to those who do not andtreating the condition can reduceaccident rates by 83%. It has beenreported that up to 1:6 HeavyGoods Vehicle (HGV) drivers arethought to have OSA and someUnions are calling for mandatorytesting for all drivers. Falling asleepat the wheel results in far moreserve injuries and likelihood ofdeath as there is no attempt atbreaking and evasive manoeuvres”.

At the time when Mr Oko foundedthe Snoring Disorders Centre in2006 there was no OSA service inLincolnshire even though localclinicians had been trying todevelop these for over a decade ina population group that is the mostobese in Europe and over 79 fatalaccidents per year (each costing£1.49 million).

The Medical Director of UnitedLincolnshire Hospitals Trust askedMr Oko to solve this problem with aprivate sector model which wouldprovide a solution to this problem.

The Snoring Disorders Centre atThe Bostonian in Lincolnshire, UK,was founded in 2006 by Mr MichaelOko, Consultant ENT Surgeon, todevelop exceptional services topatients for the diagnosis andtreatment of obstructive sleepapnoea (OSA).

OSA has been prevalent for manyyears and is associated with obesepatients in two thirds of cases, butthis condition has always beenmisunderstood the public andpoliticians. With the obesityepidemic which is spreading acrossthe world, and in particular indeveloped and wealthy countries,the impact on society of this chroniccondition is becoming moreapparent.

Although about 20% of thepopulation snore, OSA is thought toaffect between 2 and 4% of thepopulation and is at least twice ascommon in males as females. Inpractice overweight males insedentary occupations (lorry driverfor example) in their 30s and 40s

Dr Michael Oko

Interview with Dr Michael Oko - Consultant ENT surgeon and founder ofThe Snoring Disorders Centre

Visit Dr Michael Okoat stand 7E 14


January 2011 | 42

World Health Care Congress Middle East review

Short biography

Michael Oko has been a Consultant ENT Surgeon for 5 years and headof Dept of Sleep Services for 4.5yrs, ENT for 3yrs and general surgeryfor 1 yr. He qualified in 1986 and trained in London (St Mary’s & RoyalNational Throat, Nose & Ear) & Glasgow and was a Lecturer at theUniversity of Glasgow in ENT Surgery and was one of the 12 finalistsin 2005 for the Surgeon in Training medal, organised by the largestCollege of Surgeons in the world, The Royal College of SurgeonsEdinburgh for instrument design and innovation.

By 2008 Mr Oko had won the East midlands NHS Healthcare awardsfor service transformation and road fatalities had dropped to 52 savingover £40 million per year in Lincolnshire at a cost of approximately1million per year. In 2010 he was asked to present his project andfindings by the Health Services Journal (HSJ) to all commissioners ofENT services and his peer group in the UK and had treated over 1500patients of which 1200 are on CPAP and the road fatalities continue tobe stabilised at 52 per annum.

In November 2010 he was nominated for the prestigious “Excellencein Respiratory health Award” by Middle East Hospital magazine.

There were significant challengesto this as the Trust did not have alist of identified cases, no clinicspace and no equipment fordiagnostics or treatment and noagreed commissioning agreementsform the local healthcareorganisations. They was also asubstantial hurdle to overcome interms of educational awarenessabout the condition amongst thelocal population and GeneralPractitioners.

Working with the Local Trust in a50:50 partnership arrangement allthese obstacles were rapidlyovercome, with Mr Oko takingresponsibility for the purchase andprovision of all diagnostic andtreatment equipment and giving halfof the tariff income back to theNHS.

Mr Oko will be attending Arabhealth in Dubai and is seeking toreplicate his success in Lincolnshireacross the Middle East with localpartners over the next 5 years, andhe will also be attending SaudiMedicare in April 2011.

Asked about his interest in theMiddle East region, Mr Okoexplained, “Levels of obesity,hypertension and heart disease arerocketing in the wealthy MiddleEast, mainly due to the life-style outthere. People are working longhours, eating rich calorie-ladenfood, driving everywhere and notexercising enough. Beingoverweight can result in snoringwhich is a major cause ofobstructive sleep apnoea, when aperson temporarily stops breathingmany times during the night. Thisdeprives people of deep REM sleepand results in drowsiness andfatigue the next day. It’s when we’retired that we make mistakes –especially whilst driving. So it’s nosurprise that road accident rates outin Dubai and the UAE are dreadful.

“In fact road traffic accidents are thesecond major cause of deaths inthe UAE. There are 3500 fatalitiesper year from RTAs in Saudi Arabia

alone, and OSA is a possibleexplanation for this in some cases.I believe that the success I havehad in Lincolnshire can bereplicated by raising awareness ofthe condition, and forming long-term partnerships with localhospitals, doctors, and government

departments”. Mr Oko emphasisesthe importance of working with allrelevant agencies to tackle thisissue, not just in the healthcarefield, but also in transport and roadsafety. [email protected]

CPAP FOR SLEEP APNOEA

While you sleep, a CPAP machine delivers oxygen and air at a slightly higher pressure than normal air.

LIFESTYLE CHANGES

Changes to your life alone can enhance your sleep and help prevent sleep apnoeaand snoring.

SURGERY FOR SNORING

Surgery that changes the shape or sizeof the soft tissues within your mouthor ear, nose and throat surgery.

MANDIBULAR DEVICES

Devices to stop your jaw and tongue blocking your airway and causing snoring to wear at night.

Signs of Sleep Apnoea

• Loud snoring • Breath holding at night

(apnoea) • Daytime fatigue • Short term memory loss • Multiple trips to urinate

through the night • Early morning

headaches• Loss of interest in sex

[email protected]

THE SNORING DISORDERS CENTRE IS A NEW AND INNOVATIVE SERVICE LED BY CONSULTANT SURGEON MR MICHAEL OKO.

The centre provides an accurate and prompt diagnosis and treatment of various sleep problems including sleep apnoea and snoring. Problem snoring and sleep apnoea are a more widespread problem than most people think.

AWARD WINNING SERVICESIn 2008 the Snoring Disorders Centre won the NHS East MidlandsHealthcare Award for service transformation. Today, patients travel thelength and breadth of the country for Mr Oko's unique service.

Our aim is to deliver high quality clinical care in a friendly environment.We are looking for partners throughout the region

www.snorecentre.com [email protected]

OUR SERVICES

SLEEPING DISORDERS


January 2011 | 43


WWorld Health Care Congress Middle East reviewThe Inaugural World Health CareCongress Middle East is the mostprestigious health care eventconvening global thought leadersand key decision makers from allsectors of health care to shareglobal best practices on health careinnovation and improvement.

The 2010 Congress took place inAbu Dhabi, UAE. The Congressfeatured some of the leadinghealthcare experts in the regionand from all over the world.Including keynote speeches froman impressive Saudi presencerepresented by Walid Fitahi CEOof IMC Hospital Jeddah andAbdullah Amro CEP King FahadMedical City, Sultan Al SudeiryHead of Research Centre KingFaisal Hospital. Also in attendancewas Michael Reid Director Generalof Queensland Health in Australia.The event was compered by RizKhan, presenter on Al Jazeerah.

“Abu Dhabi is committed tocontinuous improvement,innovation and excellence in healthcare for all of its residents, theMiddle East in general, and toinspire health innovation andimprovement world wide. Weenvisage the event attracting a highregional and international turnout ofhealth care executives, providers,and government leaders to explorefresh ideas and unique insights,”said CEO of Health Authority - AbuDhabi (HAAD) Zaid Al-Siksek. “Thetopics to be addressed will beactionable and strategic, designedto address local and globalchallenges in quality, costeffectiveness, outcomes and newmodels for finance andimprovements in delivery.”

“There is an increasing amount ofinnovation in health care throughoutthe world, yet often dramaticallybetter health delivery practices andoutcomes are not even widelyrecognized within their owncountries,” said WHCC Chairman

Vidar Jorgenson. “Abu Dhabi isproviding a great service bysponsoring a World Health CareCongress that will focus oninnovation, identifying andpromoting these important healthcare innovations with recognitionthroughout the world, inspiring evenmore health innovation and sharingin the future.”

World Health Care Congresshighlights health issuesSeveral important announcementswere made at this year’s WorldHealth Care Congress Middle East

held at the Beach Rotana Hotel 5th –7th December. The congress saw agathering of 500 global health careleaders share best practices for thefuture of health care in the UAE, theGCC countries and abroad.

On Sunday, the Health AuthorityAbu Dhabi (HAAD), the regulator ofthe healthcare sector in the Emirateof Abu Dhabi, announced a plan toimprove health care delivery in theEmirate by sharing informationabout the quality of care patientsreceive and the clinicians whoprovide healthcare. The initiative

Vishal Bali–CEO Fortis HospitalGroup; Hamad Al Yami KingFaisal Hospital; Ali Al Sanousi,King Faisal Hospital

Mike Tanousis, Aspetar Qatar, Riz Khan

January 2011 | 44

WWorld Health Care Congress Middle East review


marks the first time Abu Dhabi willpublish detailed clinical indicatorsbased on routine data collection. DrPhilip Vetter, head of strategy atHAAD, said, “These are the first ofa series of indicators developed bythe Clinical Quality Panel. Usinginternational indicators as a basisthey give good insight into thequality of care being delivered.”

On Monday, HAAD also announcedthe official launch of an Innovators’Forum, a collection of initiativesfrom a broad range of academic,non-governmental organisation andprivate sector entities, focused onthe development of new productsand services for preventing andtreating the growing burden ofchronic diseases in the Emirate.

The Innovators’ Forum willinclude a diverse community ofleading global health careentities interested in workingwith HAAD to achieve a sharedgoal of improving the publichealth. HAAD CEO Zaid alSiksek said, “Abu Dhabi offers aprime opportunity to gatherstakeholders and impact health,

as the region brings together arare combination ofcircumstances for innovation:strong leadership, unique healthdata, and solid resources, and aunique health data systemencompassing both UAENationals and expatriates.”The urgency of theseannouncements was highlightedby the presentation of a report

on Tuesday, Diabetes in theUnited Arab Emirates: Crisis orOpportunity?, which estimatesthat 32 percent of the country’sadult population, including bothUAE nationals and expatriates,may have diabetes orprediabetes by 2020 at a cost ofAED 31.27 billion over the nextdecade if current trendscontinue.

Hussein Ekbal Abu DHABI HealthAuthority; Dr Abdullah AL Amro,CEO King Fahad Medical City

Zaid Al Siksek CEO Health Authority Abu Dhabi

January 2011 | 45

Sultan Al Sedairy – Head of Research KingFaisal Hospital,Steven Burrill CEO Burrill & Co

Access to healthcare amajor challengeUniversal access to healthcare andsustainability are major challengesfaced by many countries across theglobe, experts said on the first dayof The World Health Care Congress(WHCC) Middle East.

“I think the challenge of universalaccess is enormous and have along way to go,” said Michael Reid,Director-General of QueenslandHealth in Australia, noting that thefactors affecting access includedthe challenge of affordability,availability and healthcare delivery.Speaking at the inauguralconference in Abu Dhabi, Reid alsostressed that sustainability remainsa core issue of health systemsworldwide.

In Abu Dhabi, 98 per cent of the2.2 million population havehealth insurance coverageallowing residents instantaccess to healthcare, and thiswas made possible by thereformation of the emirate’shealth system three years ago.“We focus on three main areas inAbu Dhabi, to provide the best andthe highest standard of care for allpatients, to provide accesswherever it may be throughout ourhealth system and provideaffordable healthcare to ourstakeholders and customers,” saidZaid Al Siksek, CEO of the HealthAuthority-Abu Dhabi (HAAD).

But to sustain the government’svision, certain elements of thehealth system need to be furtherreformed. These include creating atransparent database, establishingspecialist healthcare facilities tocater to various needs of thepatients, providing incentives to theforeign workforce, developing aconsumer-driven healthcare todrive innovation and thetransformation of chronic diseasemanagement.

“Hospitals cannot do anything andeverything, hospitals need to bespecialised as 2.2 million peoplecannot afford to do everything in

every single hospital. One of the thingswe push for is the need to bespecialised, and be able to focushealthcare onto groups where we canbecome much better at what we’redoing and provide the threshold that areneeded to provide sustainable quality,”said Siksek.

Noting the important role of physiciansin the health system, Siksek proposedthe need to give them incentives inaddition to their salaries, whichultimately will give them the feeling ofownership. “We depend on the foreignworkforce in Abu Dhabi. About 85-90per cent of our workforce is not fromwithin the UAE. We need to give themincentives that are more than pay.Surely we cannot convince them to stayand help transform the healthcaresystem with just pay. They need to feelpart of the health system and this issomething that we’re looking to

transform and integrate in the system,”Siksek disclosed.

On transforming chronic diseasemanagement, Siksek said: “Chronicdisease was something that we have tointegrate into the reform process asunfortunately in Abu Dhabi, we have nochoice. Our population is relativelyyoung at an average age of 28, andchronic diseases are staggering. Thenumber of diabetics among the UAEnational population is about 22 percent.“We are looking at a hugechallenge in the next 20 years and itdoesn’t look like it’s going to get better,”he added.

The next show will be held 11-13 De-cember 2011Abu DhabiMiddle East Hospital are the officialmedia partners to the show and youcan find further details on www.world-congress.com/events/HR11004/

Ahmed Okasha, Milton Ioannides, Riz Khan

Dr Prem Jaygasi and Mike Tanousis


January 2011 | 46

medibord.com

World First Technology Medibord�

The Medibord� has been designed to enable the development of innovativesolutions for radiotherapy and MRI compatible medical devices and clinical use.

��

� Lightweight � less than 4.5kg/m²

� Rigid � impressive strength to weight ratio

� Robust � high impact resistance offers superb durability

� Ecological � 100% recyclable

� MRI Compatible � uniquely magneto-radio translucent

� Modular � ability to form and offer 2D for shaping cost effective ancillaries

Successful clinical trials carried out by Nottingham University Hospitals have provedthe Medibord� to be a revolutionary material for the use in radiotherapy and MRI scans�� #�*�� +�� <eliminating heat and the resultant image artefacts.

*�� +��

� Oncology couch tops

� Patient positioning boards and devices

� Patient transfer systems

� Emergency and temporary partitioning

� Clinical waste applications

For more information and to arrange for a clinical trial please contact us.

*�� +#�= ��<#�>�<� ��[��#�\ ��#�\]^�^]_ �� ̀��{^^}�~�� [email protected]

Most InnovativeProduct for Export

According to an InternationalDiabetes Federation report sixcountries in the Middle Eastand North African Region areamong the world’s 10 highestfor diabetes prevalence and asimilar situation applies for theIGT prevalence. Thesecountries are Bahrain, Egypt,Kuwait, Oman, Saudi Arabiaand United Arab Emirates. Theageing of populations, togetherwith socio-economic andlifestyle changes, has resultedin the dramatic increase indiabetes prevalence.

Over the past three decades, majorsocial and economic changes haveoccurred in the majority of thesenations. These include progressiveurbanization, decreasing infantmortality and increasing lifeexpectancy. Rapid economicdevelopment, especially among themore wealthy oil-producingcountries, has been associated withtremendous modification in lifestyletowards the westernized patternreflected by changes in nutrition,less physical activity, tendency toincreased obesity and moresmoking.

The explosion of diabetes in theMENA Region is mainly due totype 2 diabetes. As with manyother countries with highdiabetes prevalence, the onsetof type 2 diabetes tends tooccur at a relatively young age.An estimated 26.6 millionpeople, or 7.7% of the adultpopulation, will have diabetes in2010, with the number expectedto nearly double in the next 20years. Similarly, the number ofpeople with IGT is alsoexpected to rise markedly by2030, raising the likelihood offurther increases in theprevalence of diabetes as thecentury proceeds.

Reliable data for type 1 diabetes inchildren were also available in a numberof countries in this region. By far thelargest contribution to the total numberof children with type 1 diabetes comesfrom Egypt whose estimates accountsfor almost a quarter of the region’s totalof 54,000 cases. The range of reportedincidence varies from 22.3 per 100,000aged 0-14 years per year in Kuwait toless than 1 per 100,000 aged 0-14years in Pakistan.

Diabetes is the expected cause ofsome 290,000 deaths in this region,which will account for 11.5% of alldeaths in the 20-79 age group in2010. More women than men areexpected to die from diabetes-related causes. In the 50-59 agegroup, mortality attributable todiabetes in women accounts formore than 20% of all deaths. Inspite of the high estimates ofdiabetes prevalence in the MENARegion, the total healthcareexpenditure for diabetes isexpected to be only USD5.6 billionfor the whole region. This isprojected to account for only 1.5%of global spending. People withdiabetes in the 50-59 age group areexpected to incur the highest costs.A high percentage (80%) ofcountries that responded to the IDFmember association surveyindicated the existence of a nationaldiabetes programme. In themajority of these countries, theNDP had been implemented.Primary prevention as well asscreening and early diagnosis areimportant areas of focus in many ofthe NDPs in this region of extremelyhigh diabetes prevalence. At thesame time, NDPs monitoredcommunity awareness, and theprevalence and incidence ofdiabetes in their efforts to deal withthe diabetes burden.

Treating the diseaseThe Gulf Diabetes Specialist Center(GDSC) Medical Director is Dr.Wiam Hussein , a consultant

endocrinologist from Cleveland,USA , who is one of the best knownnames in the treatment of diabetesand endocrine disorders in theMiddle East.

Asked about the causes of a highprevalene of diabetes in the regionDr Hussein told MEH, “Diabetestype 2, the most common type, isgenetically determined but whathas changed is the environment inthe last 2 decades leading to moresedentary lifestyle and poor eatinghabits that led to an epidemic ofObesity. Obesity is the strongestrisk factor for diabetes. Theprevalence in the Gulf countries isconsidered the highest in the worldand it is thought it will double in thenext two decades. We can increasediabetes awareness and diagnoseit earlier to prevent the devastatingcomplications of the disease nut wecan also prevent the disease bychanging the poor eating habits,improve lifestyle towards healthierones and prevent obesity.”

GDSC in Bahrain is the region's firstmedical center devoted entirely tothe treatment of diabetes and itsrelated complications. In Bahrainprevalence rate of diabetes mellitusis 14.4% of the population, doublethe MENA average of 7.7%.

Dr Maha Taysir Barakat


Special feature: Diabetes in the Gulf and MENA region

January 2011 | 48


Middle East

MEH

201

0


rd

The Arab region’s leading healthcare monthly, Middle East Hospital magazine (MEH), are proud to announce the opening of nominations for our 2010 Healthcare and Innovation Awards.

Winners will be presented with their awards at Saudi Medicare 2011 by the Saudi Health Minister.

The MEH Healthcare and Innovation awards are presented annually to companies, institutions and individuals who have made an outstanding contribution to healthcare in the Middle East region.

Categories:1. Awards for most innovative products for export

2. Awards for outstanding contribution to healthcare in the Middle East

3. National and regional awards for companies that have most successfully marketed and supplied their products to hospitals in the Middle East

4. MEH excellence in healthcare awards

Middle East Hospital (MEH) magazine is the region’s leading trade publication for the medical sector of the GCC states and the rest of the Arab world.

To enter your company or hospital contact:

[email protected] visit

www.middleeasthospital.com

2010 HEALTH and INNOVATION AWARDSNominations now open

Dr Maha Taysir Barakat was therewhen the doors opened at theImperial College London DiabetesCentre in Abu Dhabi nearly fouryears ago. “At first, we would seeabout five patients a day, then itwas ten a day, and it built to 200patients a day,” recalls Dr Barakat,the consultant endocrinologist anddirector of medical and research atthe hospital. “Now it’s exceeding300 a day.”

Since that day in August 2006 morethan 20,000 patients have visitedthe hospital, particularly fordiabetes, which is prevalent in theUAE. Managing diabetes is a largefocus for healthcare providers andspending by governments in theregion. There are two main types ofthe disease: Type 1 is mostcommonly evident from earlychildhood and sufferers aredependent on insulin; while Type 2,also known as adult-onset diabetes,has been linked to obesity andother lifestyle factors.

In Abu Dhabi, nearly a third ofEmiratis are overweight and one infour shows evidence of having thedisease, government healthstatistics show. Nationally, thefigure is about 20 per cent. About25 per cent of Emirati men andalmost 40 per cent of women in thecountry are classified as obese,which puts a further strain onmedical facilities. Treating thosepatients could cost the nation morethan Dh440 million (US$119.7m) ayear, according to research fromUAE University.

Mubadala Healthcare, a division ofMubadala Development, which is astrategic investment companyowned by the Abu DhabiGovernment, has partnerships withinternational medical organisations.The link-up involves Mubadalaproviding the capital while themedical groups offer technology,expertise and staff. The investmentcompany opened the ImperialCollege London centre and it isbuilding the Cleveland Clinic AbuDhabi, which is due to open in

2012. Imperial College LondonDiabetes Centre (ICLDC) was oneof the first facilities to beestablished as part of MubadalaHealthcare’s vision to create aworld-class healthcare network inAbu Dhabi. The Centre is a primeexample of how this vision is beingrealised - addressing one of themost pressing healthcare issues inthe region by harnessing the world-renowned medical expertise ofImperial College London andcreating a centre of excellence forAbu Dhabi.

Costs of diabetes epidemic isrocketingThrough economic boom and busthealth care has remained on anupward trajectory, posting year afteryear of growth as healthcareproviders throughout the worldcope with the demands of anageing population. In the GCC,demand for care largely comesfrom populations that suffer higherrates of obesity-related diseasessuch as diabetes andcardiovascular illnesses.

Various estimates have the value ofthe GCC’s healthcare sector atbetween US$ 15 billion and US$18bn a year, a total that shouldincrease five-fold by 2025. Thegrowth in demand is fuelled by boththe governments in the Gulf and thecitizens they serve, says AmeeraYoussef, the business director atAcorn Research Group in Dubai.“Governments are getting smarter,”Ms Youssef says. “Patients are

more aware of their rights; theydon’t want to accept the standardsof health care of the past.”

To meet those demands, the UAEMinistry of Finance has said 6.4 percent of its total budget of Dh43.6bnthis year will go to health care. AbuDhabi is investing heavily in itshealthcare infrastructure as itshealth authority plans to add 2,000hospital beds to the existing 3,642in the next 10 years.

But even with that dedicatedfunding, health budgets could stillbe stretched to the limit to matchdemand from a population that isincreasing each year. AcornResearch predicts that projectedspending in the GCC by 2025 willtop US$ 57.3bn. But analysts warneven that might not be enough.Alpen Capital, a Dubai investmentbank, cautions that the regionneeds to add more than 27,000beds to meet internationalstandards.

But Dr Baraket says the region’sgrowing healthcare needs are notgoing to be met merely throughinvestment in infrastructure andhaving patients visit doctors inhospitals. “There is no point in apatient seeing a doctor who justgives tablets,” she says. “Theyneed to understand what theyshould and shouldn’t do, what theyshould and shouldn’t eat, especiallysince they only see the doctor, say,three or four times a year. This is365 days a year.”


January 2011 | 50


MEH

201

0 Health and InnovationCome and visit us at

Arab HealthStand Number

7H 58

middle east hospital magazine january 2011

Documents

international healthcare

philips healthcare

healthcare insurance

nusrate ibrahimarab

dubai healthcare city

hospital supplies

themiddle eastmeh

themiddle east34